India may have a dengue vaccine as early as next year. Developed by Japanese major Takeda, the vaccine named ‘Qdenga’ will be ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration ...

Despite high vaccination coverage, India reported 7,201 measles cases—second highest globally. Experts warn of state-wise ...

India recorded a decline of 73 per cent in measles cases and a 17 per cent reduction in rubella cases compared with 2023.

In light of the recent terror attack, India is reviewing its pharmaceutical exports to Pakistan. The Department of ...

Dr Reddy’s and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.

During the virtual launch, Shri Nadda described the campaign as a "momentous occasion" and emphasized the importance of ...

India runs the world’s largest vaccination programme for pregnant women and children –  29 million pregnant women and 26 ...

Acknowledging India’s contribution to TB vaccine research, Dr. Swaminathan noted that the overall TB vaccine pipeline remains ...

Dr. Reddy’s Laboratories will expand its partnership with Sanofi Healthcare India (SHIPL) by launching the latter’s novel drug Beyfortus (nirsevimab) in India.

Every year, during the last week of April, the world meets to observe World Immunization Week. This important initiative, led ...

Dianne Elliot took a three-week, seven-country trip that included stops in the United Kingdom, Egypt, India, Cambodia, Jordan, Indonesia and Oman. Some of those countries require ...